Clinical Evaluation of SDF Combined With KI Versus SDF in Management of Class I Carious Lesions (NCT05485272) | Clinical Trial Compass
UnknownNot Applicable
Clinical Evaluation of SDF Combined With KI Versus SDF in Management of Class I Carious Lesions
Egypt42 participantsStarted 2022-02-01
Plain-language summary
To evaluate the clinical performance of High-Viscosity Glass Ionomer (EQUIA) versus Silver Diamine Fluoride combined with Potassium Iodide (Riva Star) and Sliver Diamine Fluoride (SDF) under High-Viscosity Glass Ionomer (EQUIA) in deep class I carious lesions, over a period of one year follow-up. The null hypothesis tested in this study, that in deep class I carious lesions, the High-Viscosity Glass Ionomer (EQUIA) versus Silver Diamine Fluoride combined with Potassium Iodide (Riva Star) and Sliver Diamine Fluoride (SDF) under High-Viscosity Glass Ionomer (EQUIA) will show the same clinical performance.
Who can participate
Age range18 Years – 40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patients with deep class I carious lesions in molars, according to the international caries detection and assessment system (ICDAS), occlusal caries that scored 4 (underlying dark shadow from dentin), or 5 (Distinct cavity with visible dentin).
✓. Adults males or females.
✓. Age: 18-40 years old.
✓. Good Oral hygiene.
✓. Co-operative patients, approving to participate in the study.
✓. Teeth planned to be restored should be vital.
✓. Presence of favorable occlusion.
Exclusion criteria
✕. Patients having severe systemic diseases, allergies, or adverse medical histories.
✕. Patients complaining of sever or active periodontal disease.